Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,977 public trials 716 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

NCT00949286

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • LCC 80 - Canberra Hospital Garran, Australian Capital Territory, Australia
  • LCC 28 - Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • LCC 48 - Gosford Gosford, New South Wales, Australia
  • LCC 59 - Liverpool Hospital Liverpool, New South Wales, Australia
View all 172 locations
View Trial Details
Completed

Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid

NCT00915772

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.52.11005 Boehringer Ingelheim Investigational Site Calgary, Alberta, Canada
  • 1218.52.11003 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada
  • 1218.52.11002 Boehringer Ingelheim Investigational Site Red Deer, Alberta, Canada
  • 1218.52.11006 Boehringer Ingelheim Investigational Site Vancouver, British Columbia, Canada
View all 112 locations
View Trial Details
Completed

Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled

NCT01699932

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 422-002 Beirut, Lebanon
  • Investigational Site Number 422-001 Hazmiyeh, Lebanon
  • Investigational Site Number 643-03 Saint Petersburg, Russia
  • Investigational Site Number 643002 Saint Petersburg, Russia
View all 13 locations
View Trial Details
Completed

Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin

NCT01457911

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 156001 Beijing, China
  • Investigational Site Number 156016 Beijing, China
  • Investigational Site Number 156003 Beijing, China
  • Investigational Site Number 156018 Beijing, China
View all 22 locations
View Trial Details

Related conditions